- Home
- HXHX vs LGVN Comparison
HXHX vs LGVN Comparison
Compare HXHX & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HXHX
- LGVN
- Stock Information
- Founded
- HXHX 2003
- LGVN 2014
- Country
- HXHX China
- LGVN United States
- Employees
- HXHX N/A
- LGVN N/A
- Industry
- HXHX Trucking Freight/Courier Services
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- HXHX Industrials
- LGVN Health Care
- Exchange
- HXHX Nasdaq
- LGVN Nasdaq
- Market Cap
- HXHX 16.8M
- LGVN 16.4M
- IPO Year
- HXHX 2025
- LGVN 2021
- Fundamental
- Price
- HXHX $1.46
- LGVN $0.79
- Analyst Decision
- HXHX
- LGVN Strong Buy
- Analyst Count
- HXHX 0
- LGVN 2
- Target Price
- HXHX N/A
- LGVN $6.50
- AVG Volume (30 Days)
- HXHX 243.4K
- LGVN 330.0K
- Earning Date
- HXHX 01-01-0001
- LGVN 11-11-2025
- Dividend Yield
- HXHX N/A
- LGVN N/A
- EPS Growth
- HXHX N/A
- LGVN N/A
- EPS
- HXHX 0.26
- LGVN N/A
- Revenue
- HXHX $25,571,810.00
- LGVN $2,073,000.00
- Revenue This Year
- HXHX N/A
- LGVN N/A
- Revenue Next Year
- HXHX N/A
- LGVN N/A
- P/E Ratio
- HXHX $5.61
- LGVN N/A
- Revenue Growth
- HXHX N/A
- LGVN 68.67
- 52 Week Low
- HXHX $0.84
- LGVN $0.63
- 52 Week High
- HXHX $6.29
- LGVN $2.48
- Technical
- Relative Strength Index (RSI)
- HXHX N/A
- LGVN 45.59
- Support Level
- HXHX N/A
- LGVN $0.73
- Resistance Level
- HXHX N/A
- LGVN $0.82
- Average True Range (ATR)
- HXHX 0.00
- LGVN 0.03
- MACD
- HXHX 0.00
- LGVN 0.01
- Stochastic Oscillator
- HXHX 0.00
- LGVN 66.09
About HXHX Haoxin Holdings Limited Class A Ordinary Shares
Haoxin Holdings Ltd is engaged in the logistics industry, including container provider of temperature-controlled truckload service and urban delivery services in China, freight forwarding, cold chain transportation and other businesses. The types of goods involved are all kinds of new energy materials that require low temperature, heat preservation, and constant temperature, electronic products, medicines, meat, fruits, vegetables and others.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.